abstract |
The present disclosure describes a bispecific anti-CD3 × CD19 polypeptide complex, a bispecific anti-CD3 × CD19 polypeptide complex, comprising a first antigen-binding portion of the polypeptide complex and a second antigen-binding portion. , A method of treating a disease or disorder using a bispecific anti-CD3 × CD19 polypeptide complex, a polynucleotide encoding a bispecific anti-CD3 × CD19 polypeptide complex, said polynucleotide. Provided are compositions and pharmaceutical compositions comprising vectors and host cells comprising, as well as bispecific anti-CD3 × CD19 polypeptide complexes. |